Literature DB >> 28258176

The patellofemoral pain and osteoarthritis subscale of the KOOS (KOOS-PF): development and validation using the COSMIN checklist.

Kay M Crossley1, Erin M Macri2, Sallie M Cowan3, Natalie J Collins4, Ewa M Roos5.   

Abstract

BACKGROUND: Patellofemoral pain and osteoarthritis are prevalent and associated with substantial pain and functional impairments. Patient-reported outcome measures (PROMs) are recommended for research and clinical use, but no PROMs are specific for patellofemoral osteoarthritis, and existing PROMs for patellofemoral pain have methodological limitations. This study aimed to develop a new subscale of the Knee injury and Osteoarthritis Outcome Score for patellofemoral pain and osteoarthritis (KOOS-PF), and evaluate its measurement properties.
METHODS: Items were generated using input from 50 patients with patellofemoral pain and/or osteoarthritis and 14 health and medical clinicians. Item reduction was performed using data from patellofemoral cohorts (n=138). We used the COnsesus-based Standards for the selection of health Measurements INstruments guidelines to evaluate reliability, validity, responsiveness and interpretability of the final version of KOOS-PF and other KOOS subscales.
RESULTS: From an initial 80 generated items, the final subscale included 11 items. KOOS-PF items loaded predominantly on one factor, pain during activities that load the patellofemoral joint. KOOS-PF had good internal consistency (Cronbach's α 0.86) and adequate test-retest reliability (intraclass correlation coefficient 0.86). Hypothesis testing supported convergent, divergent and known-groups validity. Responsiveness was confirmed, with KOOS-PF demonstrating a moderate correlation with Global Rating of Change scores (r 0.52) and large effect size (Cohen's d 0.89). Minimal detectable change was 2.3 (groups) and 16 (individuals), while minimal important change was 16.4. There were no floor or ceiling effects.
CONCLUSIONS: The 11-item KOOS-PF, developed in consultation with patients and clinicians, demonstrated adequate measurement properties, and is recommended for clinical and research use in patients with patellofemoral pain and osteoarthritis. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Knee; Measurement; Osteoarthritis; Questionnaire

Mesh:

Year:  2017        PMID: 28258176     DOI: 10.1136/bjsports-2016-096776

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  20 in total

1.  Does patellar alignment or trochlear morphology predict worsening of patellofemoral disease within the first 5 years after anterior cruciate ligament reconstruction?

Authors:  Erin M Macri; Brooke E Patterson; Kay M Crossley; Josh J Stefanik; Ali Guermazi; Evelina Blomqwist; Karim M Khan; Tim S Whitehead; Hayden G Morris; Adam G Culvenor
Journal:  Eur J Radiol       Date:  2019-01-31       Impact factor: 3.528

2.  Combined distal femoral osteotomy and tibial tuberosity distalization is effective in patients presenting with patellar instability and patellofemoral pain due to patella alta and femoral malalignment.

Authors:  Julian Fluegel; Felix Zimmermann; Sebastian Gebhardt; Danko Dan Milinkovic; Peter Balcarek
Journal:  Arch Orthop Trauma Surg       Date:  2022-07-21       Impact factor: 2.928

3.  Protocol for a randomised, assessor-blinded, parallel group feasibility trial of flat flexible school shoes for adolescents with patellofemoral pain.

Authors:  Natalie Mazzella; Aaron Fox; Natalie Saunders; Danielle Trowell; Bill Vicenzino; Jason Bonacci
Journal:  J Foot Ankle Res       Date:  2022-07-05       Impact factor: 3.050

Review 4.  Patient-reported outcome measures for patellofemoral disorders: a systematic review.

Authors:  Sergio Barroso Rosa; Andrea Grant; Peter McEwen
Journal:  Arch Orthop Trauma Surg       Date:  2022-10-19       Impact factor: 2.928

5.  Measurement properties of the Knee Injury and Osteoarthritis Outcome Score Patello-Femoral questionnaire in Saudi Arabians.

Authors:  Mahamed Ateef
Journal:  PeerJ       Date:  2020-07-31       Impact factor: 2.984

6.  Cartilage Restoration of Patellofemoral Lesions: A Systematic Review.

Authors:  Renato Andrade; Joni Nunes; Betina B Hinckel; Jordan Gruskay; Sebastiano Vasta; Ricardo Bastos; J Miguel Oliveira; Rui L Reis; Andreas H Gomoll; João Espregueira-Mendes
Journal:  Cartilage       Date:  2019-12-17       Impact factor: 3.117

7.  Longitudinal analysis of the contribution of 3D patella and trochlear bone shape on patellofemoral joint osteoarthritic features.

Authors:  Tzu-Chieh Liao; Hannah Jergas; Radhika Tibrewala; Emma Bahroos; Thomas M Link; Sharmila Majumdar; Richard B Souza; Valentina Pedoia
Journal:  J Orthop Res       Date:  2020-10-05       Impact factor: 3.102

8.  Outcomes After Deepening Trochleoplasty and Concomitant Realignment in Patients With Severe Trochlear Dysplasia With Chronic Patellofemoral Pain: Results at 2-Year Follow-up.

Authors:  Felix Zimmermann; Danko Dan Milinkovic; Peter Balcarek
Journal:  Orthop J Sports Med       Date:  2021-06-07

Review 9.  Comparative effectiveness of treatments for patellofemoral pain: a living systematic review with network meta-analysis.

Authors:  Marinus Winters; Sinéad Holden; Carolina Bryne Lura; Nicky J Welton; Deborah M Caldwell; Bill T Vicenzino; Adam Weir; Michael Skovdal Rathleff
Journal:  Br J Sports Med       Date:  2020-10-26       Impact factor: 13.800

10.  HAPPi Kneecaps! Protocol for a participant- and assessor-blinded, randomised, parallel group feasibility trial of foot orthoses for adolescents with patellofemoral pain.

Authors:  Isobel C O'Sullivan; Kay M Crossley; Steven J Kamper; Marienke van Middelkoop; Bill Vicenzino; Melinda M Franettovich Smith; Hylton B Menz; Anne J Smith; Kylie Tucker; Karina T O'Leary; Natalie J Collins
Journal:  J Foot Ankle Res       Date:  2020-08-02       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.